|
Volumn 45, Issue 16, 2002, Pages 3418-3429
|
Monocyclic human tachykinin NK-2 receptor antagonists as evolution of a potent bicyclic antagonist: QSAR and site-directed mutagenesis studies
|
Author keywords
[No Author keywords available]
|
Indexed keywords
MEN 11523;
MEN 11532;
MEN 11540;
MEN 11558;
MEN 11667;
MEN 11668;
MEN 11690;
MEN 11691;
MEN 11701;
MEN 11703;
MEN 11708;
MEN 11712;
MEN 11715;
MEN 11716;
MEN 11733;
MEN 11749;
MEN 11755;
MEN 11757;
MEN 11799;
MEN 11830;
MEN 11842;
MEN 11877;
MEN 11959;
MEN 11970;
MEN 11983;
MEN 11986;
MEN 11987;
NEUROKININ 2 RECEPTOR;
NEUROKININ 2 RECEPTOR ANTAGONIST;
TACHYKININ RECEPTOR ANTAGONIST;
UNCLASSIFIED DRUG;
UNINDEXED DRUG;
ARTICLE;
DRUG BINDING SITE;
DRUG POTENCY;
DRUG RECEPTOR BINDING;
DRUG SYNTHESIS;
MOLECULAR MODEL;
POINT MUTATION;
QUANTITATIVE STRUCTURE ACTIVITY RELATION;
RECEPTOR AFFINITY;
SITE DIRECTED MUTAGENESIS;
AMINO ACID SEQUENCE;
BINDING SITES;
BINDING, COMPETITIVE;
HUMANS;
LIGANDS;
MODELS, MOLECULAR;
MOLECULAR CONFORMATION;
MOLECULAR MIMICRY;
MOLECULAR SEQUENCE DATA;
MUTAGENESIS, SITE-DIRECTED;
PEPTIDES, CYCLIC;
QUANTITATIVE STRUCTURE-ACTIVITY RELATIONSHIP;
RADIOLIGAND ASSAY;
RECEPTORS, NEUROKININ-2;
TACHYKININS;
|
EID: 0036682427
PISSN: 00222623
EISSN: None
Source Type: Journal
DOI: 10.1021/jm011127h Document Type: Article |
Times cited : (14)
|
References (16)
|